CN1201803C - Nasosinusitis treating Chinese medicine powder - Google Patents
Nasosinusitis treating Chinese medicine powder Download PDFInfo
- Publication number
- CN1201803C CN1201803C CN 03126103 CN03126103A CN1201803C CN 1201803 C CN1201803 C CN 1201803C CN 03126103 CN03126103 CN 03126103 CN 03126103 A CN03126103 A CN 03126103A CN 1201803 C CN1201803 C CN 1201803C
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- radix
- chinese medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to traditional Chinese medicine powder for treating nasosinusitis. The present invention can effectively solve the problem of treating medicine in nasosinusitis, rhinitis, chronic rhinitis and nasal septum erosion. The present invention has the technical scheme that thunberg fritillary bulbs, chuanxiong rhizomes, fructus garedeniae, kuh-seng, dahurian angelica roots, xanthium, mint, asarum from Liaoning, fried licorice roots, magnolia flowers, ligusticum sinense oliver, honeysuckle flowers, bupleurum root, forsythia fruit, lonicerae forsythiae, pilose asiabell roots and astragalus roots are manufactured into powder which is encapsuled. The present invention has the advantages of scientific and reasonable compatibility, abundant raw material, convenient and safe administration, no toxic side effect, good curative effect and easy popularization and application, and can make a positive contribution of treating nasosinusitis, allergic rhinitis, chronic rhinitis and nasal septum erosion.
Description
One, technical field
The present invention relates to a kind of sinusitis Chinese medicine powder of (comprising allergic rhinitis, chronic rhinitis, nasal interval erosion) for the treatment of clinically.
Two, background technology
Sinusitis is a kind of common pilosity, the difficult disease that easily recurs, and motherland's medical science is referred to as " nasal sinusitis ".At present the medicine of treatment sinusitis, allergic rhinitis, chronic rhinitis, nasal interval erosion is a lot, but curative effect is not good enough, and its operative treatment curative effect is low, painful big, and easily recurs and side effect arranged.This class disease prevalence in students in middle and primary schools is higher, has a strong impact on student's healthy and school achievement.Thereby how to treat above-mentioned disease be the problem that people extremely are concerned about.
Three, summary of the invention
At above-mentioned situation, the present invention's purpose just provides a kind of Chinese medicine powder of new treatment sinusitis, can solve the medication problem of treatment sinusitis effectively, the scheme of its solution is, according to the Chinese medicine and pharmacy principle, sinusitis, allergic rhinitis, chronic rhinitis, nasal interval erosion be have in the exopathogen invade, stop in the wind and cold, damp fire-transformation, qi and blood stagnation, heap soil or fertilizer over and around the roots stagnate obstructed, inaccessible nose key, wind and cold wind heat He Er returns damp and hot, nasal sinusitis category Wei Paralysis.It is purpose that its treatment is adopted to effect a permanent cure, and taking stopgap measures is means, treating both the principal and secondary aspects of a disease.Prescription is used: Bulbus Fritillariae Thunbergii, Rhizoma Chuanxiong, SHANZHIZI, Radix Sophorae Flavescentis, the Radix Angelicae Dahuricae, Fructus Xanthii, Herba Menthae, Herba Asari, Radix Glycyrrhizae (parched), Flos Magnoliae flower, Rhizoma Ligustici, Flos Lonicerae, Radix Bupleuri, Fructus Forsythiae, Herba Hyperici Erecti, Herba Schizonepetae, Radix Codonopsis, the Radix Astragali are made powder and are incapsulated and get final product, compatibility of the present invention is scientific and reasonable, abundant raw materials, taking convenience safety, have no side effect, good effect is easy to apply, and can be treatment sinusitis, allergic rhinitis, chronic rhinitis, nasal interval erosion is made positive contribution.
Four, the specific embodiment
Below in conjunction with concrete condition and embodiment the present invention is elaborated.
According to aforementioned medicine requirement, the present invention adopts by weight: 10 parts of Bulbus Fritillariae Thunbergiis, 10 parts of Rhizoma Chuanxiongs, 30 parts of SHANZHIZI, 20 parts of Radix Sophorae Flavescentiss, 20 parts of the Radixs Angelicae Dahuricae, 40 parts of Fructus Xanthii, 30 parts of Herba Menthaes, 10 parts of Herba Asari, 15 parts of Radix Glycyrrhizae (parched), Flos Magnoliae are spent 20 parts, the medicine of 20 parts of Rhizoma Ligusticis, 30 parts of Flos Loniceraes, 20 parts of Radix Bupleuri, 20 parts of Fructus Forsythiaes, 20 parts of Herba Schizonepetae, 20 parts of Radix Codonopsis, 30 parts of the Radixs Astragali, 30 parts of compositions of Herba Hyperici Erecti to be ground into powder and are sieved and make.
To make 395 gram Chinese medicine powders is example, its 395 gram Chinese medicine powder is to spend 20 grams, Rhizoma Ligustici 20 grams, Flos Lonicerae 30 grams, Radix Bupleuri 20 grams, Fructus Forsythiae 20 grams, Herba Schizonepetae 20 grams, Radix Codonopsis 20 grams, the Radix Astragali 30 grams, Herba Hyperici Erecti 30 grams to make powder through pulverizer by Bulbus Fritillariae Thunbergii 10 gram, Rhizoma Chuanxiong 10 grams, SHANZHIZI 30 grams, Radix Sophorae Flavescentis 20 grams, the Radix Angelicae Dahuricae 20 grams, Fructus Xanthii 40 grams, Herba Menthae 30 grams, Herba Asari 10 grams, Radix Glycyrrhizae (parched) 15 grams, Flos Magnoliae to cross the 150-200 mesh sieve and make detail medicated powder 395 grams, with the fine powder zero capsule of packing into, 0.5 gram Chinese medicine powder in every capsules is in order to taking.
As everybody knows, sinusitis, allergic rhinitis, chronic rhinitis, its symptom of nasal interval erosion show as dizziness, headache, feeling of fullness in the head more, feel sick, nasal obstruction, rhinorrhea, pus and blood tears, sneeze, heating and easy catching a cold, and Abwehrkraft des Koepers descends.Want to cure above-mentioned disease, Abwehrkraft des Koepers is risen, resistance against diseases strengthens, and harmful climatic factors is gone out, and gets rid of evils and sets upright, promoting blood circulation and cooling blood, the warming the meridian that reduces phlegm (expectorant is insubstantial phlegm), silt releasing and analgesia.Theoretical in view of the above and configuration medicine, the problems referred to above are solved, and this type of disease is cured.
In its compatibility: Radix Bupleuri, Herba Hyperici Erecti can be brought down a fever; Radix Codonopsis, Radix Astragali strongly invigorating primordial QI strengthening vital QI to eliminate pathogenic factors; Flos Lonicerae, Herba Schizonepetae, Herba Menthae, Radix Sophorae Flavescentis, SHANZHIZI, Radix Glycyrrhizae (parched) removing pathogenic heat from blood and toxic substance from the body; Flos Magnoliae flower, Herba Asari, the Radix Angelicae Dahuricae, Fructus Xanthii, Rhizoma Chuanxiong, sensible, the pain-alleviating and network vessel-freeing of Rhizoma Ligustici switch; Bulbus Fritillariae Thunbergiiization has insubstantial phlegm.This side is that combination expectorant, pain relieving are stimulated the menstrual flow, had one's ideas straightened out, removing heat from blood, strengthening vital QI to eliminate pathogenic factors and build up resistance and be the specific medicament of one, thus nose key malfunction is rehabilitated, clinical practice has also proved this point.Its clinical data is as follows:
1, selects the standard of case
Sinusitis, allergic rhinitis, chronic rhinitis, its condition of illness of nasal interval erosion show as dizziness, headache, feeling of fullness in the head more, feel sick, have a stuffy nose, flow dense tears, pus and blood tears, sneeze, heating and easy catching a cold, Abwehrkraft des Koepers descends, therefore, every suffer from above-mentioned condition of illness person, all as the standard of selecting case, and as treatment target.
2, diagnostic criteria
All nose key functions have obstacle, and performance has dizziness, headache, feeling of fullness in the head, feels sick, nasal obstruction, rhinorrhea, sneeze, heating has the flu symptom, diagnosable for suffering from sinusitis or rhinitis, acute rhinitis is diagnosed as chronic rhinitis not curing a still continuation patient two weeks, the rhinitis patient promptly takes place in cold whenever or outside stimulus, be diagnosed as allergic rhinitis, rhinorrhea, pus and blood tears and dizziness, headache arranged, feel sick, condition of illness person such as nasal obstruction, be diagnosed as nasal interval erosion.
3, therapeutic scheme
Oral, adult's secondary every day, each 5, every 0.5 gram, promptly each 2.5 grams, 7-12 year, every day secondary, each 3 (1.5 gram), 3-6 year, each 1-2 grain, every day secondary, and be furnished with to many groups according to treatment, make a definite diagnosis by the X line before the treatment.One week of medication takes effect, and continues medication 3-5 week again.
4, efficacy assessment standard
Cure: the symptom complete obiteration, and recurrence was not again arranged in 1 year.
Effectively: symptom has clear improvement, and can adhere to normally that work, study, life do not have tangible discomfort.
Invalid: symptom does not have improvement or obviously improves, even increase the weight of trend in addition.
5, data statistics is handled
In clinical to 300 routine sinusitis, allergic rhinitis, chronic rhinitis, nasal interval erosion patient clinical practice, wherein male 184 examples, woman's 116 examples, sinusitis 236 examples, allergic rhinitis and chronic rhinitis 48 examples, nasal interval erosion 16 examples, the age is 3-66 year, matched group adopts Western medicine or other Chinese medicine, comprises that " QIANBAI BIYAN PIAN ", " nose is comfortable ", " BIYANKANG ", " HUODAN WAN " reach " broad-spectrum antibiotic " etc.It the results are shown in following table:
| Group | The example number | Produce effects | Effectively | Invalid | Total effective rate | Cure rate |
| The treatment group | 300 | 248 | 47 | 5 | 98.3％ | 82.7％ |
| Matched group | 123 | 57 | 21 | 45 | 63.4％ | 46.3％ |
Separately count, see the following form:
| Sinusitis | Allergic rhinitis | Chronic rhinitis | Nasal interval erosion | |||
| The treatment group | Before the treatment | 236 | 18 | 30 | 16 | |
| After the treatment | Cure | 197 | 15 | 25 | 11 | |
| Effectively | 39 | 1 | 2 | 5 | ||
| Invalid | 0 | 2 | 3 | 0 | ||
| Matched group | Before the treatment | 83 | 14 | 17 | 9 | |
| After the treatment | Cure | 39 | 8 | 8 | 2 | |
| Effectively | 12 | 2 | 5 | 2 | ||
| Invalid | 32 | 4 | 4 | 5 | ||
Can clearly be seen that by above-mentioned two tables Chinese medicine powder of the present invention obviously is better than matched group, outstanding comparability is arranged.
6, conclusion
Observe through clinical practice and contrast groups treatment, the present invention has outstanding curative effect to the treatment sinusitis, and other rhinitis diseases are also had remarkable result, and total effective rate reaches 98.3%, and the present invention succeeds in developing, and is the creative contribution to the Chinese materia medica treasure-house.
Claims (2)
1, a kind of Chinese medicine powder for the treatment of sinusitis is characterized in that this Chinese medicine powder spends 20 parts, 20 parts of Rhizoma Ligusticis, 30 parts of Flos Loniceraes, 20 parts of Radix Bupleuri, 20 parts of Fructus Forsythiaes, 20 parts of Herba Schizonepetae, 20 parts of Radix Codonopsis, 30 parts of the Radixs Astragali, 30 parts of medicines of forming of Herba Hyperici Erecti to be ground into powder by 10 parts of Bulbus Fritillariae Thunbergiis, 10 parts of Rhizoma Chuanxiongs, 30 parts of SHANZHIZI, 20 parts of Radix Sophorae Flavescentiss, 20 parts of the Radixs Angelicae Dahuricae, 40 parts of Fructus Xanthii, 30 parts of Herba Menthaes, 10 parts of Herba Asari, 15 parts of Radix Glycyrrhizae (parched), Flos Magnoliae and sieve and make.
2, the Chinese medicine powder of treatment sinusitis according to claim 1, it is characterized in that it being to spend 20 grams, Rhizoma Ligustici 20 grams, Flos Lonicerae 30 grams, Radix Bupleuri 20 grams, Fructus Forsythiae 20 grams, Herba Schizonepetae 20 grams, Radix Codonopsis 20 grams, the Radix Astragali 30 grams, Herba Hyperici Erecti 30 gram crushing screenings to make 395 gram Chinese medicine powders and incapsulate, 0.5 gram Chinese medicine powder in every capsules by Bulbus Fritillariae Thunbergii 10 grams, Rhizoma Chuanxiong 10 grams, SHANZHIZI 30 grams, Radix Sophorae Flavescentis 20 grams, the Radix Angelicae Dahuricae 20 grams, Fructus Xanthii 40 grams, Herba Menthae 30 grams, Herba Asari 10 grams, Radix Glycyrrhizae (parched) 15 grams, Flos Magnoliae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03126103 CN1201803C (en) | 2003-04-01 | 2003-04-01 | Nasosinusitis treating Chinese medicine powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03126103 CN1201803C (en) | 2003-04-01 | 2003-04-01 | Nasosinusitis treating Chinese medicine powder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1440806A CN1440806A (en) | 2003-09-10 |
| CN1201803C true CN1201803C (en) | 2005-05-18 |
Family
ID=27770484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03126103 Expired - Fee Related CN1201803C (en) | 2003-04-01 | 2003-04-01 | Nasosinusitis treating Chinese medicine powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1201803C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101224276B (en) * | 2008-01-09 | 2011-02-09 | 于国录 | Chinese patent medicine for treating rhinitis |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100358548C (en) * | 2006-05-22 | 2008-01-02 | 周宣岩 | Chinese medicine rinsing liquid after nasal endoscope operation |
| CN102697902B (en) * | 2012-04-18 | 2014-07-09 | 王桂琴 | Chinese medicine composition for treating chronic rhinitis |
| CN103599326B (en) * | 2013-11-19 | 2016-04-13 | 太和县中医院 | A kind of Chinese medicine for the treatment of acute sinusitis |
| CN103977080B (en) * | 2014-05-29 | 2016-04-27 | 高广忠 | A kind of Chinese medicine dropping for the treatment of rhinitis and preparation method thereof |
| CN106138745B (en) * | 2016-08-31 | 2021-03-23 | 张明 | Traditional Chinese medicine preparation for treating rhinitis and preparation method thereof |
| CN106161968B (en) * | 2016-09-20 | 2018-12-11 | 照旷科技(上海)有限公司 | A kind of method of cell monitoring platform courses camera shooting |
| CN106509218A (en) * | 2016-10-26 | 2017-03-22 | 深圳市康恒凯草本生物科技有限公司 | Rhinitis-treating tea as well as preparation method and usage thereof |
| WO2018090345A1 (en) * | 2016-11-18 | 2018-05-24 | 韩婷 | Gel for prevention and treatment of respiratory allergic disease and preparation method thereof |
-
2003
- 2003-04-01 CN CN 03126103 patent/CN1201803C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101224276B (en) * | 2008-01-09 | 2011-02-09 | 于国录 | Chinese patent medicine for treating rhinitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1440806A (en) | 2003-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872418B (en) | Medicine for treating pelvic inflammation | |
| CN103432534B (en) | Traditional Chinese prescription for treating hyperplasia of mammary glands | |
| CN101385828B (en) | Traditional Chinese medicine for treating urgent and chronic inflammation of upper respiratory tract | |
| CN102940853A (en) | Navel paste for treating mammary gland hyperplasia diseases | |
| CN1201803C (en) | Nasosinusitis treating Chinese medicine powder | |
| CN102363020B (en) | Chinese medicinal composition for treating proliferation of mammary gland | |
| CN1167445C (en) | Chinese medicine for treating rhinitis and nasosinusitis | |
| CN101837100A (en) | Medicinal composition for curing gynecopathy and application thereof | |
| CN102283951A (en) | Chinese medicinal composition for treating anaphylactoid purpura and thrombocytopenic purpura | |
| CN101249205B (en) | Chinese medicine for curing cold and all lesion | |
| CN1193782C (en) | Medicament for treating lumbar and cervical vertebra pain | |
| CN1099980A (en) | Chinese-medicinal capsule for treatment of psoriasis | |
| CN100411672C (en) | A medicinal composition for treatment of psoriasis | |
| CN104971327A (en) | Traditional Chinese medicinal preparation for treating wind-heat type common cold | |
| CN100364605C (en) | Specific pellet for treating cold, and preparation method | |
| CN104435545A (en) | Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning | |
| CN104825610A (en) | Preparation method of pharmaceutical composition for treating chronic pelvic inflammatory disease | |
| CN103566219A (en) | Traditional Chinese medicine composition for treating cold | |
| CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
| CN101966329A (en) | Medicament for treating rash | |
| CN1306946C (en) | Snuffle dredging capsule | |
| CN1424095A (en) | Analgestic plaster | |
| CN105727180A (en) | Chinese herbal medicine composition for treating mammary gland hyperplasia and preparation method thereof | |
| CN103340987B (en) | Pharmaceutical composition for abatement of fever | |
| CN104162104A (en) | Medicine for treating chronic atrophic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050518 |